NCT06926621: A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type I
- State
- Under way
- Phase
- Phase 2
- People
- 44 planned
- Started
- 28 Apr 2025
- Primary completion
- 30 Jan 2029
- Arms
- VX-670
- Results
- None posted
- 14 Apr 2025: Trial registered
- 28 Apr 2025: Trial started